2022
DOI: 10.7150/thno.64035
|View full text |Cite
|
Sign up to set email alerts
|

Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices

Abstract: The demand of glucose monitoring devices and even of updated guidelines for the management of diabetic patients is dramatically increasing due to the progressive rise in the prevalence of diabetes mellitus and the need to prevent its complications. Even though the introduction of the first glucose sensor occurred decades ago, important advances both from the technological and clinical point of view have contributed to a substantial improvement in quality healthcare. This review aims to bring together purely te… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
35
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 89 publications
(43 citation statements)
references
References 169 publications
0
35
0
Order By: Relevance
“…Although an old patent based on an assumptive fluorescence of glucose excited at 308 nm is reported, glucose actually has no detectable fluorescence when excited in the visible or near-UV range ( Khalil, 2004 ; Pullano et al, 2022 ). Fluorescence technologies make instead use of fluorophores that, once bound to the analyte (e.g., glucose), are able to emit fluorescent light with distinctive optical properties (mostly, excitation and detection wavelengths).…”
Section: Blood Glucose Monitoring Devicesmentioning
confidence: 99%
“…Although an old patent based on an assumptive fluorescence of glucose excited at 308 nm is reported, glucose actually has no detectable fluorescence when excited in the visible or near-UV range ( Khalil, 2004 ; Pullano et al, 2022 ). Fluorescence technologies make instead use of fluorophores that, once bound to the analyte (e.g., glucose), are able to emit fluorescent light with distinctive optical properties (mostly, excitation and detection wavelengths).…”
Section: Blood Glucose Monitoring Devicesmentioning
confidence: 99%
“…Specific oxidases are immobilised onto the electrode surface, converting the non-electroactive biological target to H 2 O 2 for the subsequent in vitro detection of the attendant targeted molecule. This type of screening has been mainly used in the enzymatic detection of glucose by involving glucose oxidase (GOx) assistance in biosensing due to their crucial role in controlling glucose in diabetic patients [ 49 ].…”
Section: Hydrogen Peroxide Electrochemical Detectionmentioning
confidence: 99%
“…In healthcare modern diagnostic approaches and therapies, implantable bioelectronic devices can improve the clinical outcome of the patient, obtaining a large amount of data [ 7 , 8 , 9 ]. Innovative devices are usually light, allowing the patient to conduct normal daily activities [ 10 , 11 , 12 ]. Energy storage is by far one of the bottlenecks, preventing efficient energy management [ 13 ].…”
Section: Introductionmentioning
confidence: 99%